Event Details
- Financial Period: First quarter ended June 30, 2026
- Results Announcement Date: Wednesday, August 05, 2026
- Earnings Call Date: Wednesday, August 05, 2026
- Earnings Call Time: 16:00 hours
Conference Call Access Details
Universal Access Number (all networks/countries): +91 22 6280 1130 or +91 22 7115 8031
International Toll-Free Numbers:
- USA: 18667462133
- UK: 08081011573
- Singapore: 8001012045
- Hong Kong: 800964448
DiamondPass Link: Available via the company's provided link for immediate access without wait time.
Participants are requested to dial in 10 minutes before the scheduled time.
Company Background
Shilpa Medicare Limited is described as an integrated pharmaceutical group with business interests in:
- Niche Oncology & Non-oncology APIs
- Peptides
- Polymers
- Differentiated finished dosage formulations including orally dispersible films & transdermal patches
- Biological portfolio
The company provides end-to-end CDMO services to global pharmaceutical companies across all business segments, supported by four R&D units and seven manufacturing facilities.